• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首发精神分裂谱系障碍患者抑郁的病程和伴随情况:一项 24 个月的纵向研究。

The course and concomitants of depression in first-episode schizophrenia spectrum disorders: A 24-month longitudinal study.

机构信息

Department of Psychiatry, Stellenbosch University, Cape Town 7500, South Africa.

Department of Psychiatry, Stellenbosch University, Cape Town 7500, South Africa.

出版信息

Psychiatry Res. 2021 Apr;298:113767. doi: 10.1016/j.psychres.2021.113767. Epub 2021 Jan 29.

DOI:10.1016/j.psychres.2021.113767
PMID:33545422
Abstract

Depressive symptoms are common in schizophrenia and have been associated with both favourable and unfavourable outcomes. We studied the longitudinal course of depressive symptoms and explored their temporal relationships with other manifestations of the illness and its treatment. This longitudinal cohort study included 126 antipsychotic naïve or only briefly treated patients with first-episode schizophrenia spectrum disorders treated with a long-acting antipsychotic over 24 months. Depressive symptoms were assessed at three monthly intervals using the Calgary Depression Scale for Schizophrenia and changes over time were assessed using linear mixed-effect models for continuous repeated measures. Depressive symptoms were most prominent at baseline with highly significant reductions during the first three months of treatment and maintenance of improvement thereafter. Most improvement occurred with antipsychotic treatment alone, with few patients requiring additional antidepressants. We also found that depressive symptoms were associated with positive symptoms, better insight and poorer quality of life, but not with negative symptoms, extrapyramidal symptoms, substance use or cumulative antipsychotic dose.There were few differences between patients who met criteria for depression during the acute phase of treatment and those in the post-acute phase.

摘要

抑郁症状在精神分裂症中很常见,与有利和不利的结果都有关。我们研究了抑郁症状的纵向病程,并探讨了其与疾病其他表现及其治疗的时间关系。这项纵向队列研究包括 126 名首次发作的精神分裂症谱系障碍的抗精神病药物初治或仅短期治疗的患者,他们在 24 个月内接受长效抗精神病药物治疗。使用 Calgary 精神分裂症抑郁量表每三个月评估一次抑郁症状,并使用线性混合效应模型评估连续重复测量的时间变化。抑郁症状在基线时最为明显,治疗前三个月有显著下降,此后保持改善。大多数改善发生在单独使用抗精神病药物时,很少有患者需要额外使用抗抑郁药。我们还发现,抑郁症状与阳性症状、更好的洞察力和较差的生活质量有关,但与阴性症状、锥体外系症状、物质使用或累积抗精神病药物剂量无关。在治疗急性期符合抑郁症标准的患者和急性后阶段的患者之间几乎没有差异。

相似文献

1
The course and concomitants of depression in first-episode schizophrenia spectrum disorders: A 24-month longitudinal study.首发精神分裂谱系障碍患者抑郁的病程和伴随情况:一项 24 个月的纵向研究。
Psychiatry Res. 2021 Apr;298:113767. doi: 10.1016/j.psychres.2021.113767. Epub 2021 Jan 29.
2
Changes in insight over the first 24 months of treatment in schizophrenia spectrum disorders.精神分裂症谱系障碍患者治疗的头 24 个月内洞察力的变化。
Schizophr Res. 2019 Apr;206:394-399. doi: 10.1016/j.schres.2018.10.013. Epub 2018 Oct 29.
3
Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia.首发精神分裂症患者接受长效抗精神病药物维持治疗 24 个月期间精神病发作的预测因素。
Schizophr Res. 2020 Nov;225:55-62. doi: 10.1016/j.schres.2019.11.025. Epub 2019 Nov 22.
4
[Antipsychotics in bipolar disorders].[双相情感障碍中的抗精神病药物]
Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5.
5
Depression in first-episode schizophrenia.首发精神分裂症中的抑郁
Am J Psychiatry. 1993 Nov;150(11):1643-8. doi: 10.1176/ajp.150.11.1643.
6
The trajectories and correlates of two negative symptom subdomains in first-episode schizophrenia.首发精神分裂症两个阴性症状亚领域的轨迹和相关性。
Schizophr Res. 2022 May;243:17-23. doi: 10.1016/j.schres.2022.02.017. Epub 2022 Feb 25.
7
Trajectories of depressive symptoms in the acute phase of psychosis: Implications for treatment.精神病急性期抑郁症状的轨迹:对治疗的启示。
J Psychiatr Res. 2018 Aug;103:219-228. doi: 10.1016/j.jpsychires.2018.06.003. Epub 2018 Jun 2.
8
Cannabis use and clinical outcome in people with first-episode schizophrenia spectrum disorders over 24 months of treatment.24 个月治疗期间首发精神分裂谱系障碍患者的大麻使用与临床结局。
Psychiatry Res. 2021 Aug;302:114022. doi: 10.1016/j.psychres.2021.114022. Epub 2021 May 19.
9
A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.奥氮平与氟哌啶醇治疗精神分裂症原发性阴性症状和神经认知缺陷的随机对照试验
J Clin Psychiatry. 2007 Mar;68(3):368-79. doi: 10.4088/jcp.v68n0303.
10
Olanzapine: an updated review of its use in the management of schizophrenia.奥氮平:其在精神分裂症治疗中应用的最新综述
Drugs. 2001;61(1):111-61. doi: 10.2165/00003495-200161010-00011.

引用本文的文献

1
AI-based prediction of depression symptomatology in first-episode psychosis patients: insights from the EUFEST and RAISE-ETP clinical trials.基于人工智能对首发精神病患者抑郁症状的预测:来自EUFEST和RAISE - ETP临床试验的见解
Psychol Med. 2025 Jul 30;55:e221. doi: 10.1017/S0033291725100950.
2
Insight and suicidality in first-episode psychosis: The mediating role of depression.首发精神病中的洞察力与自杀倾向:抑郁的中介作用。
Schizophr Res. 2025 Jan;275:189-195. doi: 10.1016/j.schres.2024.12.013. Epub 2025 Jan 3.
3
Pseudoneurotic Symptoms in the Schizophrenia Spectrum: A Longitudinal Study of Their Relation to Psychopathology and Clinical Outcomes.
精神分裂症谱系中的假性神经症状:对其与精神病理学和临床结果关系的纵向研究。
Schizophr Bull. 2024 Jul 27;50(4):871-880. doi: 10.1093/schbul/sbad185.
4
The role of insight, social rank, mindfulness and self-compassion in depression following first episode psychosis.首发精神病后抑郁中洞察、社会等级、正念和自我同情的作用。
Clin Psychol Psychother. 2023 Nov-Dec;30(6):1393-1406. doi: 10.1002/cpp.2881. Epub 2023 Jul 12.
5
Depressive Features in Individuals with First Episode Psychosis: Psychopathological and Treatment Considerations from A 2-Year Follow-Up Study.首发精神病患者的抑郁特征:一项为期2年的随访研究中的精神病理学及治疗考量
Clin Neuropsychiatry. 2023 Feb;20(1):39-47. doi: 10.36131/cnfioritieditore20230105.